BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
1076 results:

  • 1. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
    Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany.
    Reese M; Eichelmann AK; Nowacki TM; Pascher A; Sporn JC
    Langenbecks Arch Surg; 2024 Apr; 409(1):113. PubMed ID: 38589714
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis.
    Eskandarion MR; Eskandarieh S; Tutunchi S; Shakoori Farahani A; Shirkoohi R
    Clin Exp Med; 2024 Mar; 24(1):59. PubMed ID: 38554188
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
    Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
    Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Effectiveness of minimally invasive surgery in the treatment of pancreatic acinar cell carcinoma].
    Tao M; Yuan CH; Ma CL; Jiang B; Li L; Wang HY; Xiu DR
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):950-955. PubMed ID: 38514344
    [No Abstract]    [Full Text] [Related]  

  • 6. Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinoma.
    Wei MX; Yang Z; Wang PP; Zhao XK; Song X; Xu RH; Hu JF; Zhong K; Lei LL; Han WL; Yang MM; Zhou FY; Han XN; Fan ZM; Li J; Wang R; Li B; Wang LD
    Cancer Med; 2024 Mar; 13(5):e7015. PubMed ID: 38491808
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis.
    Park JH; Shin JI; Lim BJ
    Histopathology; 2024 Jun; 84(7):1079-1091. PubMed ID: 38362762
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Textbook oncologic outcomes are associated with increased overall survival in patients with pancreatic head cancer after undergoing laparoscopic pancreaticoduodenectomy.
    Zhang J; Cai H; Zhang M; Wang X; Cai Y; Peng B
    World J Surg Oncol; 2024 Feb; 22(1):43. PubMed ID: 38317188
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
    Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
    Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Time Kills: Impact of Socioeconomic Deprivation on Timely Access to Guideline-Concordant Treatment in Foregut cancer.
    Fonseca AL; Ahmad R; Amin K; Tripathi M; Vobbilisetty V; Richman JS; Hearld L; Bhatia S; Heslin MJ
    J Am Coll Surg; 2024 Apr; 238(4):720-730. PubMed ID: 38205919
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk factors for death from other diseases after curative gastrectomy and lymph node dissection for gastric cancer.
    Hanyu T; Ichikawa H; Kano Y; Ishikawa T; Muneoka Y; Hirose Y; Miura K; Tajima Y; Shimada Y; Sakata J; Wakai T
    BMC Surg; 2024 Jan; 24(1):16. PubMed ID: 38191419
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Usefulness of the preoperative inflammation-based prognostic score and the ratio of visceral fat area to psoas muscle area on predicting survival for surgically resected adenocarcinoma of the esophagogastric junction.
    Uchida S; Sohda M; Tateno K; Watanabe T; Shibasaki Y; Nakazawa N; Kuriyama K; Sano A; Yokobori T; Sakai M; Ogawa H; Shirabe K; Saeki H
    Esophagus; 2024 Apr; 21(2):157-164. PubMed ID: 38112929
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis.
    Mi J; Wang R; Han X; Ma R; Li H
    Medicine (Baltimore); 2023 Dec; 102(48):e36228. PubMed ID: 38050202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
    Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
    Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments.
    Santullo F; Ferracci F; Abatini C; Halabieh MAE; Lodoli C; D'Annibale G; Di Cesare L; D'Agostino L; Pecere S; Di Giorgio A; Strippoli A; Pacelli F
    Langenbecks Arch Surg; 2023 Nov; 408(1):437. PubMed ID: 37973620
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular profile of gastric adenocarcinoma, relevant epidemiological factors - Systematic review and meta-analysis relating sex with Epstein-Barr virus and unstable microsatellites subtypes.
    Santos GOD; Nunes WA; Júnior WF; Botega LG; Roehe AV
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):109-118. PubMed ID: 37932908
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Skeletal Muscle Mass Before Second-line Chemotherapy Correlates With Subsequent prognosis and Rate of Late-line Chemotherapy in Patients With Unresectable gastric cancer.
    Matsunaga T; Satio H; Sakano YU; Makinoya M; Shimizu S; Shishido Y; Miyatani K; Kono Y; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    Anticancer Res; 2023 Nov; 43(11):5051-5059. PubMed ID: 37909949
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic role of the log odds of positive lymph nodes in Western patients with resected gastric cancer: A comparison with the 8th edition of the TNM staging system.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Am J Clin Pathol; 2024 Feb; 161(2):186-196. PubMed ID: 37901915
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis.
    Shou C; Chen Z; Li Z; Yang W; Zhang Q; Bai H; Yu J
    Scand J Gastroenterol; 2024; 59(2):239-245. PubMed ID: 37865826
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 54.